Want to join the conversation?
$GPN has raised its outlook for FY17 adjusted EPS to a range of $3.45-3.55, reflecting growth of 16-19% over FY16. The company now expects FY17 adjusted operating margin to expand by as much as 50 BPs, and continues to expect adjusted net revenue to range from $3.2-3.3Bil, or a growth of 47-52% over FY16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.